In this context, BC was more effective than CS overexpressing COLII (p < .05) (36.30‐fold vs. GM10), SOX‐9 (9.20‐fold vs. GM10) and AGN (16.13‐fold vs. GM10). This evidence concerns the gene SOX9 and breast cancer.